Kiniksa Pharmaceuticals International, Plc
Clinical trials sponsored by Kiniksa Pharmaceuticals International, Plc, explained in plain language.
-
New drug aims to stop recurring heart lining pain
Disease control Recruiting nowThis study tests a new medicine called KPL-387 for people who have repeated episodes of pericarditis, a painful inflammation of the lining around the heart. The goal is to see if the drug can reduce flare-ups and pain in patients who still have symptoms despite using standard tre…
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 26, 2026 11:46 UTC
-
New hope for heart inflammation sufferers: drug switch study launches
Disease control Recruiting nowThis study tests a new drug, KPL-387, for people with recurrent pericarditis (repeated heart lining inflammation) that is currently well-controlled with standard treatments. About 80 adults will switch from their usual therapy to KPL-387 alone to see if it prevents flare-ups and …
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 22, 2026 13:54 UTC